We are live on ! Find out more
CWG

C WorldWide Group Portfolio holdings

AUM $4.15B
1-Year Est. Return 13.14%
This Fund
S&P 500
This Quarter Est. Return
+9.34%
1 Year Est. Return
+13.14%
3 Year Est. Return
+63.19%
5 Year Est. Return
+70.18%
10 Year Est. Return
+417.82%
AUM
$4.15B
AUM Growth
-$512M
Cap. Flow
-$812M
Cap. Flow %
-19.59%
Top 10 Hldgs %
61.56%
Holding
102
New
5
Increased
22
Reduced
45
Closed
5

Top Buys

Rank Stock Value
1
AVGO icon
Broadcom
AVGO
+$170M
2
NU icon
Nu Holdings
NU
+$61.8M
3
RSG icon
Republic Services
RSG
+$26.9M
4
NEE icon
NextEra Energy
NEE
+$13.1M
5
INSM icon
Insmed
INSM
+$12.1M

Top Sells

Rank Stock Value
1
TMO icon
Thermo Fisher Scientific
TMO
+$257M
2
ICE icon
Intercontinental Exchange
ICE
+$153M
3
GOOG icon
Alphabet (Google) Class C
GOOG
+$144M
4
UBER icon
Uber
UBER
+$98.3M
5
AMZN icon
Amazon
AMZN
+$63.7M

Sector Composition

Rank Sector Weight
1 Financials 23.35%
2 Technology 17.66%
3 Healthcare 14.52%
4 Industrials 11.76%
5 Consumer Discretionary 10.28%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
RPRX icon
26
Royalty Pharma
RPRX
$26.1B
$26.5M 0.64%
471,881
-189,895
-29% -$9.88M
ELV icon
27
Elevance Health
ELV
$90.8B
$25.1M 0.61%
65,000
– –
TCOM icon
28
Trip.com Group
TCOM
$24.6B
$24.4M 0.59%
613,630
+12,463
+2% +$618K
VRTX icon
29
Vertex Pharmaceuticals
VRTX
$131B
$22.9M 0.55%
46,057
– –
PEN icon
30
Penumbra
PEN
$12.5B
$22.7M 0.55%
72,000
– –
KRYS icon
31
Krystal Biotech
KRYS
$10.3B
$21.5M 0.52%
57,809
-10,000
-15% -$2.99M
NBIX icon
32
Neurocrine Biosciences
NBIX
$15.9B
$21.1M 0.51%
125,000
– –
SCI icon
33
Service Corp International
SCI
$11.2B
$20.1M 0.48%
264,157
+34,727
+15% +$2.72M
MDT icon
34
Medtronic
MDT
$116B
$19.9M 0.48%
255,000
– –
SE icon
35
Sea Limited
SE
$65.1B
$19M 0.46%
198,560
+4,953
+3% +$435K
SNPS icon
36
Synopsys
SNPS
$76.2B
$16.6M 0.4%
37,250
-115
-0.3% -$54.1K
META icon
37
Meta Platforms (Facebook)
META
$1.65T
$15.9M 0.38%
28,283
-3,762
-12% -$2.3M
PRVA icon
38
Privia Health
PRVA
$2.61B
$15.7M 0.38%
610,000
– –
BMRN icon
39
BioMarin Pharmaceuticals
BMRN
$12.7B
$15.3M 0.37%
267,851
– –
PODD icon
40
Insulet
PODD
$9.15B
$15.2M 0.37%
99,908
– –
NVCR icon
41
NovoCure
NVCR
$1.81B
$14.7M 0.36%
971,784
– –
ALGN icon
42
Align Technology
ALGN
$10.7B
$14.1M 0.34%
83,428
– –
WAT icon
43
Waters Corp
WAT
$40.1B
$13.6M 0.33%
36,321
-121
-0.3% -$41.3K
MSCI icon
44
MSCI
MSCI
$40.3B
$13.5M 0.33%
24,132
-76
-0.3% -$44.3K
ALKS icon
45
Alkermes
ALKS
$7.71B
$13.1M 0.32%
250,000
– –
CLH icon
46
Clean Harbors
CLH
$17B
$12.7M 0.31%
42,397
-7,474
-15% -$2.21M
FERG icon
47
Ferguson
FERG
$43.1B
$12.5M 0.3%
52,568
-170
-0.3% -$41K
HSAI
48
Hesai Group
HSAI
$2.72B
$12.4M 0.3%
679,558
+9,385
+1% +$192K
BSX icon
49
Boston Scientific
BSX
$62.3B
$11.9M 0.29%
280,000
+100,000
+56% +$5.43M
RMD icon
50
ResMed
RMD
$31.5B
$11.7M 0.28%
59,987
+4,048
+7% +$839K
1
2
3 4 5

Similar funds

MSI
Mitsui Sumitomo Insurance Tokyo, Japan $4.15B AUM
LWCA
Locust Wood Capital Advisers New York $4.15B AUM 31.06% 1-Year Est. Return
CC
Chicago Capital Chicago, Illinois $4.15B AUM 31.09% 1-Year Est. Return
JFG
JMG Financial Group Downers Grove, Illinois $4.14B AUM 21.49% 1-Year Est. Return
CCMIC
Cardinal Capital Management Inc (Canada) Winnipeg, Manitoba, Canada $4.13B AUM 31.23% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
GCM
Gates Capital Management New York $4.16B AUM 21% 1-Year Est. Return
FMII
Farmers & Merchants Investments Inc Lincoln, Nebraska $4.13B AUM 32.58% 1-Year Est. Return

C WorldWide Group's Q2 2026 Portfolio in Review

As of Q2 2026, C WorldWide Group held 102 positions worth $4.15B, down 11% from $4.66B the previous quarter. Its ten largest holdings account for 62% of the portfolio.

C WorldWide Group withdrew a net $812M in Q2 2026, closing 5 positions and reducing 45 holdings. Its most notable exit was Uber, an estimated $98.3M position sold in full.

By sector, the portfolio is most concentrated in Financials at 23% of assets, down from 25% a quarter earlier, followed by Technology and Healthcare.

Against the trend, C WorldWide Group opened a new position in Broadcom worth $160M.

  • C WorldWide Group's largest Q2 2026 buy was Broadcom: 424,815 shares worth $160M.
  • C WorldWide Group added most to Nu Holdings in Q2 2026, an estimated $61.8M increase.
  • C WorldWide Group's biggest Q2 2026 reduction was Thermo Fisher Scientific, cutting an estimated $257M.
  • C WorldWide Group fully exited Uber in Q2 2026, selling an estimated $98.3M.
  • C WorldWide Group's ten largest holdings make up 62% of its $4.15B portfolio in Q2 2026.
  • C WorldWide Group opened 5 new positions and closed 5 in Q2 2026.
  • C WorldWide Group's portfolio value fell 11% quarter-over-quarter to $4.15B.

Based on C WorldWide Group's 13F filing for Q2 2026, filed 4 Aug 2026.